Medication-Related Osteonecrosis of Jaws (MRONJ) Prevention and Diagnosis: Italian Consensus Update 2020

Adjuvant denosumab in early breast-cancer

(2020) Paul de Boissieu et al.   LANCET ONCOLOGY

Alveolar bone histological necrosis observed prior to extractions in patients, who received bone‐targeting agents

(2020) Ourania Nicolatou‐Galitis et al.   ORAL DISEASES

Medication-related osteonecrosis of the jaw. Implant presence-triggered osteonecrosis: Case series and literature review

(2019) M.F. Escobedo et al.   Journal of Stomatology Oral and Maxillofacial Surgery

Workshop of European Task Force on Medication Related Osteonecrosis of the Jaw.Current challenges

(2019) Morten Schiodt et al.   ORAL DISEASES

Prevalence and risk factors of medication-related osteonecrosis of the jaw in osteoporotic and breast cancer patients: a cross-sectional study

(2019) Ana Laura Soares et al.   SUPPORTIVE CARE IN CANCER

OSTEOPOROTIC FRACTURES DURING BISPHOSPHONATE DRUG HOLIDAY

(2018) Brittany Bindon et al.   Endocrine Practice

Bisphosphonate Drug Holiday and Fracture Risk: A Population-Based Cohort Study

(2018) Annette L Adams et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Zoledronic Acid Induces Site-Specific Structural Changes and Decreases Vascular Area in the Alveolar Bone

(2018) Mariana Quirino Silveira Soares et al.   JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY

Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study

(2018) Noopur Raje et al.   LANCET ONCOLOGY

Imaging of Radiation- and Medication-Related Osteonecrosis

(2018) Sanjay M. Mallya et al.   RADIOLOGIC CLINICS OF NORTH AMERICA

Replacing zoledronic acid with denosumab is a risk factor for developing osteonecrosis of the jaw

(2018) Tomoko Higuchi et al.   Oral Surgery Oral Medicine Oral Pathology Oral Radiology

The Dental Management of Patients at Risk of Medication-Related Osteonecrosis of the Jaw: New Paradigm of Primary Prevention

(2018) Olga Di Fede et al.   Biomed Research International

Osteonecrosis of the jaw related to non-antiresorptive medications: a systematic review

(2018) Ourania Nicolatou-Galitis et al.   SUPPORTIVE CARE IN CANCER

Medication-related osteonecrosis of the jaw: definition and best practice for prevention, diagnosis, and treatment

(2018) Ourania Nicolatou-Galitis et al.   Oral Surgery Oral Medicine Oral Pathology Oral Radiology

Adjudication of osteonecrosis of the jaw in phase III randomized controlled trials of denosumab: a systematic review

(2017) Paul de Boissieu et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Drug holidays from bisphosphonates and denosumab in postmenopausal osteoporosis: EMAS position statement

(2017) Panagiotis Anagnostis et al.   MATURITAS

Time to onset of bisphosphonate-related osteonecrosis of the jaws: a multicentre retrospective cohort study

(2017) PPL Fung et al.   ORAL DISEASES

Zoledronate suppressed angiogenesis and osteogenesis by inhibiting osteoclasts formation and secretion of PDGF-BB

(2017) Si-yong Gao et al.   PLoS One

A 5-year retrospective longitudinal study on the incidence and the risk factors of osteonecrosis of the jaws in patients treated with zoledronic acid for bone metastases from solid tumors

(2017) M Manfredi et al.   Medicina Oral Patologia Oral y Cirugia Bucal

Identifying MRONJ-affected bone with digital fusion of functional imaging (FI) and cone-beam computed tomography (CBCT): case reports and hypothesis

(2017) Gayathri Subramanian et al.   Oral Surgery Oral Medicine Oral Pathology Oral Radiology

Osteonecrosis of jaw beyond antiresorptive (bone-targeted) agents: new horizons in oncology

(2016) Vittorio Fusco et al.   Expert Opinion On Drug Safety

Medication-Related Osteonecrosis of the Jaw Around Dental Implants

(2016) Ilaria Giovannacci et al.   JOURNAL OF CRANIOFACIAL SURGERY

Medication-related osteonecrosis of the jaw associated with bisphosphonates and denosumab in osteoporosis

(2016) J Bagan et al.   ORAL DISEASES

Osteonecrosis of the jaw induced by receptor activator of nuclear factor-kappa B ligand (Denosumab) - Review

(2016) CC de Oliveira et al.   Medicina Oral Patologia Oral y Cirugia Bucal

Up to a quarter of patients with osteonecrosis of the jaw associated with antiresorptive agents remain undiagnosed

(2015) Stefano Fedele et al.   BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY

Drug induced osteonecrosis of the jaw

(2015) Issam S. Hamadeh et al.   CANCER TREATMENT REVIEWS

Staging of osteonecrosis of the jaw requires computed tomography for accurate definition of the extent of bony disease

(2014) Alberto Bedogni et al.   BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY

Epidemiology, clinical manifestations, risk reduction and treatment strategies of jaw osteonecrosis in cancer patients exposed to antiresorptive agents

(2014) Giuseppina Campisi et al.   Future Oncology

American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw—2014 Update

(2014) Salvatore L. Ruggiero et al.   JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY

Managing the care of patients receiving antiresorptive therapy for prevention and treatment of osteoporosis

(2014) John W. Hellstein et al.   JOURNAL OF THE AMERICAN DENTAL ASSOCIATION

Notoriety bias in a database of spontaneous reports: the example of osteonecrosis of the jaw under bisphosphonate therapy in the French national pharmacovigilance database

(2014) Paul de Boissieu et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Bisphosphonate Therapy for Osteoporosis: Benefits, Risks, and Drug Holiday

(2012) Michael McClung et al.   AMERICAN JOURNAL OF MEDICINE

The relationship of denosumab pharmacology and osteonecrosis of the jaws

(2012) John Malan et al.   Oral Surgery Oral Medicine Oral Pathology Oral Radiology

Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases

(2011) F. Saad et al.   ANNALS OF ONCOLOGY

Surgery-triggered and non surgery-triggered Bisphosphonate-related Osteonecrosis of the Jaws (BRONJ): A retrospective analysis of 567 cases in an Italian multicenter study

(2011) Paolo Vescovi et al.   ORAL ONCOLOGY

Nonexposed Variant of Bisphosphonate-associated Osteonecrosis of the Jaw: A Case Series

(2010) Stefano Fedele et al.   AMERICAN JOURNAL OF MEDICINE

Bisphosphonates: restrictions for vasculogenesis and angiogenesis: inhibition of cell function of endothelial progenitor cells and mature endothelial cells in vitro

(2009) Thomas Ziebart et al.   Clinical Oral Investigations

Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ): Initial Discovery and Subsequent Development

(2009) Salvatore L. Ruggiero   JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY

American Association of Oral and Maxillofacial Surgeons Position Paper: Bisphosphonate-Related Osteonecrosis of the Jaws—2009 Update: The Need to Refine the BRONJ Definition

(2009) Giuseppe Colella et al.   JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY

Bisphosphonate-associated jawbone osteonecrosis: a correlation between imaging techniques and histopathology

(2008) Alberto Bedogni et al.   ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS